Rare Diseases
Expertise supporting rare diseases
According to the National Institutes of Health (NIH), a disease is considered rare if it affects fewer than 200,000 individual in the United States. The NIH currently identifies roughly 7,000 diseases as rare or "orphan" diseases. Approximately 60% of all breakthrough therapies approved to by the Food and Drug Administration (FDA) are indicated for rare diseases.
US Bioservices dispenses limited distribution and exclusive treatments for a number of rare diseases, for example:
Sickle cell anemia
Congenital sucrase-isomaltase deficiency (CSID) / genetic sucrase-isomaltase deficiency (GSID)
Dupuytren's contracture
Idiopathic thrombocytopenic purpura
Peyronie's disease